Does OBINUTUZUMAB Cause Neutropenic sepsis? 46 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Neutropenic sepsis have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.3% of all adverse event reports for OBINUTUZUMAB.
46
Reports of Neutropenic sepsis with OBINUTUZUMAB
0.3%
of all OBINUTUZUMAB reports
8
Deaths
39
Hospitalizations
How Dangerous Is Neutropenic sepsis From OBINUTUZUMAB?
Of the 46 reports, 8 (17.4%) resulted in death, 39 (84.8%) required hospitalization, and 11 (23.9%) were considered life-threatening.
Is Neutropenic sepsis Listed in the Official Label?
Yes, Neutropenic sepsis is listed as a known adverse reaction in the official FDA drug label for OBINUTUZUMAB.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Neutropenic sepsis?
CYCLOPHOSPHAMIDE (841)
CARBOPLATIN (757)
DEXAMETHASONE (684)
DOXORUBICIN (652)
RITUXIMAB (633)
VINCRISTINE (607)
ETOPOSIDE (569)
METHOTREXATE (411)
CISPLATIN (395)
DOCETAXEL (351)
Which OBINUTUZUMAB Alternatives Have Lower Neutropenic sepsis Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE